Women's involvement in clinical trials: historical perspective and future implications

Area of Science:

• Clinical pharmacology and drug development.
• Sex-based differences in medicine.
• Health equity in research.

Background:

• Historical underrepresentation of women in clinical trials.
• Inadequate analysis of sex-specific data in past research.
• Impact on understanding medication efficacy and safety in women.

Purpose of the Study:

• To review the evolution of women's inclusion in clinical trials for prescription drugs.
• To highlight progress made in addressing sex-specific data analysis.
• To provide recommendations for future research and clinical practice.

Main Methods:

• Literature review of historical and contemporary clinical trial practices.
• Analysis of regulatory agency initiatives and guidelines.
• Synthesis of current considerations for researchers and clinicians.

Main Results:

• Significant advancements in policies promoting women's participation in trials.
• Increased focus on analyzing sex-specific outcomes and responses.
• Ongoing challenges remain in fully integrating sex as a biological variable.

Conclusions:

• Continued efforts are essential to ensure equitable representation and analysis of women in clinical trials.
• Adoption of sex-specific considerations is vital for personalized medicine and improved patient outcomes.
• Collaboration among researchers, clinicians, and policymakers is key to advancing this field.